Furo[3,2-b]furan-2-(3H)-ones
US4552895A · kind A · utility
1Cited by
5References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 14, 1983 |
| Grant date | Nov 12, 1985 |
| Priority date | — |
| Expiry date | Mar 14, 2003 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The invention provides for certain compounds derived from ascorbic acid and their formulations which are useful in inhibiting angiogenesis in mammals.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.